Abstract
Colorectal cancer (CRC) is the second most deadly cancer in the US. Early detection improves CRC outcomes. Multiple options are endorsed for CRC screening; however, adherence remains a challenge and underutilization of CRC screening has been documented among Medicaid enrollees (between 12.3–21.3% in some studies). The multi-target stool DNA (mt-sDNA) test, which includes patient and provider navigation support, may afford greater adherence to CRC screening in this population. We assessed cross-sectional adherence with mt-sDNA in a sample of patients with Medicaid.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
